Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intramuscular tranexamic acid for prevention of postpartum haemorrhage after vaginal delivery
PACTR202609465949909Phase 4Not yet recruiting
- Sponsor
- Fiona Gideon Kisis
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms), sponsored by Fiona Gideon Kisis. Primary endpoint: Incidence of primary postpartum haemorrhage. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202609465949909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202609465949909.